We are live on
!
Find out more
RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
83 hedge funds and large institutions have $39.7M invested in GALENA BIOPHARMA INC COM in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
50% more call options, than puts
Call options by funds: $4.78M | Put options by funds: $3.18M
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
6% more funds holding
Funds holding: 78 → 83 (+5)
6% less capital invested
Capital invested by funds: $42.1M → $39.7M (-$2.43M)
Holders
83
Holders Change
+5
Holders Change %
+6.41%
% of All Funds
2.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
28
Reduced
22
Closed
6
Calls
$4.78M
Puts
$3.18M
Net Calls
+$1.6M
Net Calls Change
+$129K
Top Buyers
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$376K |
| 2 |
Morgan Stanley
New York
|
-$212K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$108K |
| 4 |
Goldman Sachs
New York
|
-$90.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$67K |
